These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5402682)

  • 21. [Benziodarone in hyperuricemia due to renal insufficiency].
    Boine L
    Minerva Med; 1973 Jan; 64(4):157-9. PubMed ID: 4568713
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of benziodarone on hyperuricemia in gout].
    Cottet J; Vittu C
    Presse Med (1893); 1967 May; 75(26):1355-6. PubMed ID: 6026564
    [No Abstract]   [Full Text] [Related]  

  • 23. The dual actions of morin (3,5,7,2',4'-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity.
    Yu Z; Fong WP; Cheng CH
    J Pharmacol Exp Ther; 2006 Jan; 316(1):169-75. PubMed ID: 16169936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Physiopathology and treatment of hyperuricemia and gout].
    Louyot P; Pourel J; Gaucher A; Montet Y
    Rein Foie; 1971; 13():103-27. PubMed ID: 5147550
    [No Abstract]   [Full Text] [Related]  

  • 25. [Gout treatment with a dibromine derivative of benzofuran].
    Delbarre F; Auscher C; Saporta L; de Grey A; Danchot J
    Rev Rhum Mal Osteoartic; 1973 Apr; 40(4):275-7. PubMed ID: 4716906
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F; Saporta L; de Géry A; Jabre E
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
    Gerbaux JO; Rodhain J
    Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):98-115. PubMed ID: 5302427
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of hyperuricemia.
    Lowenthal DT
    Am Fam Physician; 1976 Jul; 14(1):98-100. PubMed ID: 937167
    [No Abstract]   [Full Text] [Related]  

  • 29. Uricosurics and xanthine oxidase inhibitors: a single-dose assay.
    McMahon FG
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):414-7. PubMed ID: 4987349
    [No Abstract]   [Full Text] [Related]  

  • 30. [Coronary diseases, hyperuricemia and benziodarone. Personal considerations].
    Veglia L
    Minerva Med; 1974 Oct; 65(72):3795-8. PubMed ID: 4608791
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of benziodarone on blood levels of uric acid in terminal uremia].
    Cheli O; Maffei E
    Minerva Med; 1972 Jan; 63(1):10-3. PubMed ID: 5059248
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new medicine for gout ailments: benziodarone].
    Deshayes P; Cardinael Y
    Rhumatologie; 1967; 19(7):255-8. PubMed ID: 5619724
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum uric acid and the risk of hypertension and chronic kidney disease.
    Feig DI
    Curr Opin Rheumatol; 2014 Mar; 26(2):176-85. PubMed ID: 24419747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Benzbromarone in the treatment of hyperuricemias].
    Ravera R
    Minerva Med; 1975 Mar; 66(17):783-800. PubMed ID: 1093064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 37. Repair of Bone Erosion With Effective Urate-Lowering Therapy in a Patient With Tophaceous Gout.
    Sakaguchi S
    Arthritis Rheumatol; 2021 Feb; 73(2):231. PubMed ID: 32892502
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of urate-lowering agents on arrhythmia vulnerability in post-infarcted rat hearts.
    Lee TM; Lin SZ; Chang NC
    J Pharmacol Sci; 2016 May; 131(1):28-36. PubMed ID: 27129614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern therapy of gout].
    Delbarre F; Saporta L; De Gery A; Panahi F
    Clin Ter; 1968 Jul; 46(2):103-22. PubMed ID: 5704842
    [No Abstract]   [Full Text] [Related]  

  • 40. The dual actions of Paederia scandens extract as a hypouricemic agent: xanthine oxidase inhibitory activity and uricosuric effect.
    Yan H; Ma Y; Liu M; Zhou L
    Planta Med; 2008 Sep; 74(11):1345-50. PubMed ID: 18729039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.